Pinnacle Family Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,131
Closed -$818K 102
2023
Q1
$818K Buy
5,131
+66
+1% +$10.1K 0.5% 45
2022
Q4
$819K Sell
5,065
-105
-2% -$16.1K 0.58% 38
2022
Q3
$694K Buy
5,170
+228
+5% +$32.7K 0.6% 35
2022
Q2
$757K Buy
4,942
+1,696
+52% +$259K 0.62% 35
2022
Q1
$526K Buy
+3,246
New +$472K 0.28% 64
2018
Q2
Sell
-2,161
Closed -$205K 65
2018
Q1
$205K Hold
2,161
0.12% 64
2017
Q4
$209K Buy
+2,161
New +$204K 0.1% 69

Other funds holding ABBV

Pinnacle Family Advisors's ABBV Position: Q2 2023 in Review

Pinnacle Family Advisors sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 5,131 shares — an estimated $818K sold.

Pinnacle Family Advisors first reported a position in ABBV in Q4 2017 and held it in 7 quarters. The position peaked at $819K in Q4 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Pinnacle Family Advisors reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Pinnacle Family Advisors sold 5,131 AbbVie shares in Q2 2023, an estimated $818K.
  • Pinnacle Family Advisors first reported a position in AbbVie in Q4 2017 and held it in 7 quarters.
  • Pinnacle Family Advisors's AbbVie position peaked at $819K in Q4 2022.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Pinnacle Family Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.